Literature DB >> 16713482

Etanercept therapy in two patients with psoriasis and concomitant hepatitis C.

Clara De Simone, Andrea Paradisi, Rodolfo Capizzi, Angelo Carbone, Massimo Siciliano, Pier Luigi Amerio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16713482     DOI： 10.1016/j.jaad.2005.11.1035

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  8 in total

Review 1.  Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: a review and analysis of 36 cases.

Authors:  M Afshar; A D Martinez; R L Gallo; T R Hata
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-06-01       Impact factor: 6.166

Review 2.  Management of psoriasis patients with hepatitis B or hepatitis C virus infection.

Authors:  Claudio Bonifati; Viviana Lora; Dario Graceffa; Lorenzo Nosotti
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

3.  TNF-alpha inhibitors and ustekinumab for the treatment of psoriasis: therapeutic utility in the era of IL-17 and IL-23 inhibitors.

Authors:  Julie J Hong; Edward K Hadeler; Megan L Mosca; Nicholas D Brownstone; Tina Bhutani; Wilson J Liao
Journal:  J Psoriasis Psoriatic Arthritis       Date:  2022-01-12

Review 4.  Long-term efficacy of biologics in dermatology.

Authors:  Leslie Castelo-Soccio; Abby S Van Voorhees
Journal:  Dermatol Ther       Date:  2009 Jan-Feb       Impact factor: 2.851

Review 5.  Tumor necrosis factor-α inhibitors and chronic hepatitis C: a comprehensive literature review.

Authors:  Maurizio Pompili; Marco Biolato; Luca Miele; Antonio Grieco
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

6.  Long-term safety of anti-TNF adalimumab in HBc antibody-positive psoriatic arthritis patients: a retrospective case series of 8 patients.

Authors:  R Laurenti; F Giovannangeli; E Gubinelli; M T Viviano; A Errico; L Leoni; E Ballanti; A Migliore
Journal:  Clin Dev Immunol       Date:  2013-03-27

7.  Clinical use of anti-TNF therapy and increased risk of infections.

Authors:  Tauseef Ali; Sindhu Kaitha; Sultan Mahmood; Abdul Ftesi; Jordan Stone; Michael S Bronze
Journal:  Drug Healthc Patient Saf       Date:  2013-03-28

Review 8.  Systemic immunobiological, immunosuppressant, and oncologic agents for the treatment of dermatologic diseases during the SARS-CoV-2 (COVID-19) pandemic emergency: A quick review for a quick consultation.

Authors:  Giovanni Paolino; Santo Raffaele Mercuri; Pietro Bearzi; Carlo Mattozzi
Journal:  Dermatol Ther       Date:  2020-06-24       Impact factor: 3.858
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.